Composition
- Active ingredients
- CONCIZUMAB 300MG/3ML (100MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CONCIZUMAB 300MG/3ML (100MG/ML) · SolutionThis page
- CONCIZUMAB 60MG/1.5ML (40MG/ML) · SolutionBLA761428-001 · Prescription
- CONCIZUMAB 150MG/1.5ML (100MG/ML) · SolutionBLA761428-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761428.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Alhemo
- Active substance
- concizumab
- Route
- Injection
- Dosage form
- Solution
- Applicant
- Novo Nordisk Inc
- Status
- Prescription
- FDA approval
- 31 Jul 2025
- Application
- BLA761428-003